| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $1.6M | — | +24.8% |
| SG&A Expense | $2.4M | — | +28.3% |
| Operating Income | -$3.9M | — | -26.9% |
| Pre-tax Income | -$3.9M | — | -28.0% |
| Income Tax | $0 | — | — |
| Net Income | -$3.9M | — | -28.0% |
| EPS (Basic) | -$0.25 | — | -8.7% |
| EPS (Diluted) | -$0.25 | — | -8.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.1M | +386.0% | +213.4% |
| Accounts Receivable | $5K | +460.1% | — |
| Current Assets | $10.8M | +256.4% | +177.9% |
| Total Assets | $12.1M | +141.3% | +105.3% |
| Current Liabilities | $1.5M | +45.1% | +21.0% |
| Total Liabilities | $1.6M | +34.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.5M | — | +19.4% |
| Capital Expenditures | $15K | — | — |
| Investing Cash Flow | -$37K | — | -71.3% |
| Financing Cash Flow | $10.5M | — | +501.4% |
| Free Cash Flow | -$2.5M | — | +18.9% |
| +9.7% |
| Stockholders' Equity | $10.5M | +175.7% | +137.8% |